Ibuprofen Pfleger (Ibuprofen D,l-Lysinate)

Ibuprofen D,l-Lysinate inhibits the cyclooxygenase enzymes COX‑1 and COX‑2, which blocks the conversion of arachidonic acid to prostaglandins. This reduction in prostaglandin levels diminishes pain signaling, lowers body temperature, and curtails the inflammatory response.

The appropriate dose of Ibuprofen Pfleger is determined by a qualified prescriber based on the individual’s age, weight, medical condition, and response to therapy. Patients should follow the specific instructions provided on the product label or by their healthcare professional.

Safety of ibuprofen during pregnancy or lactation depends on the trimester and clinical circumstances. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using Ibuprofen Pfleger to weigh potential benefits against risks.

To order Ibuprofen Pfleger, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibuprofen Pfleger and naproxen belong to the same NSAID class and share similar mechanisms of COX inhibition. Ibuprofen generally has a shorter half‑life, requiring more frequent dosing, while naproxen provides longer‑lasting relief. Choice between them depends on patient tolerance, dosing convenience, and specific clinical considerations.

Ibuprofen Pfleger should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, excessive heat and direct sunlight, and ensure the container is tightly closed to maintain stability.

Ibuprofen Pfleger is taken orally, usually with a full glass of water. It may be taken with or without food; taking it with food can help reduce mild gastrointestinal discomfort. Patients should swallow tablets whole and avoid crushing or chewing them unless directed otherwise.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, and renal or hepatic impairment. Patients should seek immediate medical attention if they experience black stools, vomiting blood, sudden swelling, difficulty breathing, or marked changes in urine output.

Individuals with known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal ulcers, severe heart failure, uncontrolled hypertension, or advanced renal or hepatic disease should avoid Ibuprofen Pfleger unless specifically advised by a healthcare professional.